Navigation Links
Regulus Appoints Victor Knopov, Ph.D. as Vice President, Pharmaceutical Development
Date:11/27/2012

LA JOLLA, Calif., Nov. 27, 2012 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today the appointment of Victor Knopov, Ph.D. to its executive management team as Vice President, Pharmaceutical Development.  Dr. Knopov joined Regulus from Nitto Denko Technical Corporation where he served as Director, Chemistry Manufacturing Control since 2010. 

"Victor is a recognized expert in oligonucleotide drug delivery with over thirty years of experience," said Neil W. Gibson, Ph.D., Regulus' Chief Scientific Officer. "He will strengthen our accomplished management team and provide pharmaceutical development expertise as we advance our microRNA therapeutic programs toward the clinic."

"Regulus' mature product platform and established leadership in the microRNA field make joining the team an exciting opportunity for me," said Dr. Knopov.  "I look forward to driving our microRNA therapeutic programs into clinical development."

Dr. Knopov has extensive knowledge of Chemistry, Manufacturing and Control, or CMC, development for various technology platforms including commercial production of enzymes, small anticancer liposomal products as well as advanced delivery systems for antisense, plasmids and siRNA based on lipids, polymer nanoparticles and conjugated systems. Prior to joining Nitto Denko Technical Corporation, from 2008 to 2010, Dr. Knopov was Chief Operating Officer at Diversified Bio-Medics, Inc. and an executive management consultant for CMC development at EnGene, Inc. and Marina Biotech, Inc.  From 1997 to 2008, Dr. Knopov held various pharmaceutical manufacturing positions at Inex Pharmaceuticals Corporation where he led development for several pharmaceutical and biotech companies.

About Regulus

Regulus Therapeutics Inc. (NA
'/>"/>

SOURCE Regulus Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Regulus Receives Allowance from Japan and U.S. Patent Offices for HCV Intellectual Property, Expanding Leading Worldwide Patent Estate
2. Regulus Therapeutics Appoints Bruce Carter to its Board of Directors
3. Regulus Files Registration Statement for Proposed Initial Public Offering
4. Regulus to Present at the Lazard Capital Markets Healthcare Conference
5. Arecor Appoints Dr. Sarah Howell as Chief Operating Officer
6. Elsevier / MEDai Appoints Tom Zajac as New President
7. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
8. Hybrid Fuels, Inc. Appoints Industry Expert as New CEO
9. BioStorage Technologies Appoints New Member to Board of Directors
10. Selexis SA Appoints Yemi Onakunle as Vice President of Strategic and Market Development
11. Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 28, 2014  Next month, executives from clinical trial marketing ... events beginning with Patient-Centered Clinical Trials 2014 , to ... Boston , September 4-5. Patient recruitment experts Bonnie ... Fleishman will share insights on the benefits of employing ... tactics – from media to mobile apps – can be ...
(Date:8/28/2014)... USA (PRWEB) August 27, 2014 Scientists, ... month for SPIE Laser Damage 2014 symposium. ... materials for high-power lasers will run 14-17 September. The ... for optics and photonics . , The premier conference ... understanding laser damage to optical materials will engage researchers ...
(Date:8/28/2014)... Whitehouse Laboratories is excited to announce that ... PTI Inspection Systems that will enable it to ... leak testing method development and validation programs using the ... part of this agreement, Whitehouse Labs has taken delivery ... developed and manufactured by PTI. The HVLD (high ...
(Date:8/27/2014)... 27, 2014 Reportlinker.com announces that ... in its catalogue: Global Biodegradable ... http://www.reportlinker.com/p02316661/Global-Biodegradable-Packaging-Materials-Market-2014-2018.html About Biodegradable ... are readily decomposed by the action of ... packaging in terms of raw materials, production ...
Breaking Biology Technology:BBK Worldwide Leads Sessions at Key September Events 2Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 2Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 3Whitehouse Labs Renews Partnership with PTI Inspection Systems 2Whitehouse Labs Renews Partnership with PTI Inspection Systems 3Global Biodegradable Packaging Materials Market 2014-2018 2Global Biodegradable Packaging Materials Market 2014-2018 3Global Biodegradable Packaging Materials Market 2014-2018 4Global Biodegradable Packaging Materials Market 2014-2018 5Global Biodegradable Packaging Materials Market 2014-2018 6Global Biodegradable Packaging Materials Market 2014-2018 7
... Nov. 20 Wyeth (NYSE: WYE ... been promoted to President,Technical Operations & Product Supply ... aspects of technical operations and product supply for,Wyeth, ... units. He succeeds Charles Portwood, 58, who ...
... meeting of the Board,of Directors of Wyeth (NYSE: ... share on the outstanding shares of Preferred Stock was declared,payable ... close of business,on December 12, 2008. , ... research-driven pharmaceutical and,health care products companies. It is a ...
... Inc.,(Nasdaq: HOLX ), a leading developer, manufacturer ... products dedicated to,serving the healthcare needs of women, today ... the investment community who will be attending the RSNA,(Radiological ... This meeting will ...
Cached Biology Technology:Wyeth Names Michael Kamarck President, Technical Operations & Product Supply 2Hologic, Inc. to Host Investor Reception at the RSNA Trade Show 2
(Date:8/29/2014)... Ebola researcher from the University of Texas Medical Branch at ... three monoclonal antibodies can completely protect monkeys against a lethal ... at a time when the disease is severe. , Thomas ... for Nature discussing advances in Ebola treatment research. ... among the most deadly of pathogens, with fatality rates of ...
(Date:8/29/2014)... prolific bloomer Emiliania huxleyi , can grow without ... contradicts the common view that E. huxleyi ... of thiamine in the ocean to survive. , "It,s ... says CIFAR Senior Fellow Alexandra Worden , co-author ... fellows John Archibald (Dalhousie University), Adrin ...
(Date:8/28/2014)... of America (ESA) is pleased to announce the selection ... the Society. Honorary Membership acknowledges those who have served ... in the affairs of the Society that has reached ... by the ESA Governing Board and then voted on ... at the Awards Ceremony at Entomology 2014, ESA,s Annual ...
Breaking Biology News(10 mins):Leading Ebola researcher at UTMB says there's an effective treatment for Ebola 2Not all phytoplankton in the ocean need to take their vitamins 2Not all phytoplankton in the ocean need to take their vitamins 3Fred Baxendale selected as Honorary Member of the Entomological Society of America 2
... New research by academics at The University of Nottingham has ... the genes of the honeybee. The study, published in ... decision taken by the European Commission to temporarily ban three ... deaths. There is growing evidence connecting the decline in ...
... on our physical environment for many things clean water, ... among others. Yet it has been challenging to figure out ... so-called "ecosystem services" in any given landscape because ... another. Two ecologists at the University of WisconsinMadison ...
... -- A new study by Valerie Hu, Ph.D., professor ... (GW) School of Medicine and Health Sciences (SMHS), reports that ... group in a 2010 study, regulates a large number of ... this gene, in part, because this gene can act as ...
Cached Biology News:Insecticide causes changes in honeybee genes, research finds 2Mapping the benefits of our ecosystems 2Mapping the benefits of our ecosystems 3GW researcher discovers new regulatory autism gene 2
Allophycocyanin (APC) anti-human CD193 (CCR3, CKR3) 25 tests...
CCNI Antibody...
Rabbit polyclonal to IL23 P19 ( Abpromise for all tested applications). Antigen: Synthetic 16 amino acid peptide from near the amino terminus of human IL23 P19 Entrez Gene ID: 51561 Swiss...
3M Imidazole Solution 125 ml...
Biology Products: